Skip to main content

Evidence from the Partnerships

Explore the tangible results and data-driven outcomes achieved through our Antimicrobial Stewardship (AMS) Centers of Excellence Program and discover compelling evidence of the program's success in improving AMS across diverse healthcare settings.

  • December 06, 2024

    A New Dawn in Improving Laboratory Capacity and Diagnostic Practice

    Previous studies have identified many key causes of AMR in Kenya including, lack of laboratory capacity, healthcare worker knowledge and prolonged surgical prophylaxis.

  • December 04, 2024

    A New Antimicrobial Susceptibility Testing Assay Evaluated with Positive Blood Cultures for Antimicrobial-Resistant Bacterial Pathogens

    Policlinico Universitario Agostino Gemelli in Italy, recently evaluated the new bioMerieux VITEK® REVEAL™ AST assay for bacterial organisims that cause bloodstream infections.

  • November 30, 2024

    Antimicrobial Stewardship Programs in a Mexican Private Healthcare System

    Discover how a self-assessment survey showed the status of Antimicrobial stewardship programs (ASP) in 12 hospitals from CHRISTUS MUGUERZA Healthcare System.

  • November 26, 2024

    Blood Culture Process Improvement

    Henry Ford Health explored how optimizing their blood culture worksteam, from sample intake to results can directly impact patient care and management.

  • November 22, 2024

    Blood Culture Quality and Turnaround Time

    An exploration of key performance indicators in teaching hospitals and description of blood culture workflows.

  • November 20, 2024

    Determination and Tracking of Blood Culture Contamination

    This study from Tampa General Hospital assessed the trends and accuracy of blood culture contamination rates by comparing data obtained from CLARION™.

  • November 17, 2024

    Diagnosis of Central Nervous System Infections

    A peer-reviewed evaluation of the impact of BIOFIRE® FILMARRAY® Meningoencephalitis (ME) Panel in children with suspected Central Nervous System (CNS)  infections.

  • November 16, 2024

    Evaluation of the BIOMÉRIEUX EPISEQ® Software for Whole-Genome Multi-Locus Sequence Typing-Based (wgMLST) Bacterial Strain Typing

    This study from Tampa General Hospital compared BIOMÉRIEUX EPISEQ® CS  results to four groups of different species commonly isolated in hospital-acquired infections.

  • November 13, 2024

    Impact of Intervention Using Kaizen Method in Blood Culture Workflow and Turnaround Time

    Laboratory processes can be perfected if they are constantly evaluated. Kaizen provides the opportunity to optimize lab work and deliver results in critical processes.

  • November 11, 2024

    Impact of Lab Automation and Reorganization on Bloodstream Infections Management in ICU

    Learn how the lab enhanced its operations by acquiring the WASPLab® automation system and reorganizing improved antimicrobial stewardship and patient care.